GoodRx Holdings Price to Book Ratio 2019-2024 | GDRX
Historical price to book ratio values for GoodRx Holdings (GDRX) over the last 10 years. The current price to book ratio for GoodRx Holdings as of February 24, 2025 is 2.65.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
GoodRx Holdings Price/Book Ratio Historical Data | |||
---|---|---|---|
Date | Stock Price | Book Value per Share | Price to Book Ratio |
2025-02-24 | 4.84 | 2.65 | |
2024-09-30 | 6.94 | $1.83 | 3.79 |
2024-06-30 | 7.80 | $1.77 | 4.41 |
2024-03-31 | 7.10 | $1.68 | 4.22 |
2023-12-31 | 6.70 | $1.93 | 3.47 |
2023-09-30 | 5.63 | $2.21 | 2.54 |
2023-06-30 | 5.52 | $2.26 | 2.45 |
2023-03-31 | 6.25 | $2.09 | 3.00 |
2022-12-31 | 4.66 | $2.05 | 2.27 |
2022-09-30 | 4.67 | $1.99 | 2.35 |
2022-06-30 | 5.92 | $2.06 | 2.88 |
2022-03-31 | 19.33 | $1.99 | 9.74 |
2021-12-31 | 32.68 | $2.08 | 15.74 |
2021-09-30 | 41.02 | $2.12 | 19.32 |
2021-06-30 | 36.01 | $2.09 | 17.27 |
2021-03-31 | 39.02 | $1.91 | 20.44 |
2020-12-31 | 40.34 | $1.82 | 22.21 |
2020-09-30 | 55.60 | $1.94 | 28.61 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $1.845B | $0.750B |
GoodRx Holdings Inc. provides consumer-focused digital healthcare platform. GoodRx Holdings Inc. is based in Santa Monica, California. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $150.904B | 28.19 |
Elevance Health (ELV) | United States | $87.590B | 11.69 |
CVS Health (CVS) | United States | $79.455B | 11.63 |
Cencora (COR) | United States | $47.362B | 17.19 |
DiDi Global (DIDIY) | China | $23.670B | 0.00 |
Natera (NTRA) | United States | $20.908B | 0.00 |
ICON (ICLR) | Ireland | $16.429B | 14.61 |
Revvity (RVTY) | United States | $13.985B | 23.45 |
BioMerieux (BMXMF) | France | $13.758B | 0.00 |
Viatris (VTRS) | United States | $13.595B | 4.19 |
Doximity (DOCS) | United States | $13.537B | 70.40 |
Solventum (SOLV) | United States | $13.178B | 0.00 |
Avantor (AVTR) | United States | $11.895B | 17.47 |
CochLear (CHEOY) | Australia | $11.072B | 0.00 |
Medpace Holdings (MEDP) | United States | $10.491B | 27.26 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $9.952B | 0.00 |
HealthEquity (HQY) | United States | $9.484B | 47.58 |
Charles River Laboratories (CRL) | United States | $8.719B | 16.52 |
Sonic Healthcare (SKHHY) | Australia | $8.501B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $6.224B | 31.72 |
Bausch + Lomb (BLCO) | Canada | $5.573B | 25.50 |
Organon (OGN) | United States | $3.884B | 3.96 |
Sotera Health (SHC) | United States | $3.814B | 20.40 |
BrightSpring Health Services (BTSG) | United States | $3.382B | 71.93 |
Surgery Partners (SGRY) | United States | $3.198B | 36.46 |
Concentras Parent (CON) | United States | $2.951B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.613B | 0.00 |
GeneDx Holdings (WGS) | United States | $2.610B | 316.67 |
Ardent Health Partners (ARDT) | United States | $2.014B | 0.00 |
PACS (PACS) | United States | $1.980B | 0.00 |
Progyny (PGNY) | United States | $1.961B | 39.71 |
Teladoc Health (TDOC) | United States | $1.961B | 0.00 |
Premier (PINC) | United States | $1.690B | 10.82 |
Agilon Health (AGL) | United States | $1.500B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.409B | 0.00 |
Pediatrix Medical (MD) | United States | $1.346B | 11.28 |
CareDx (CDNA) | United States | $1.146B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $1.026B | 8.12 |
Establishment Labs Holdings (ESTA) | $0.986B | 0.00 | |
Embecta (EMBC) | United States | $0.798B | 5.47 |
Auna S.A (AUNA) | Luxembourg | $0.598B | 0.00 |
SBC Medicals (SBC) | United States | $0.484B | 0.00 |
MultiPlan (MPLN) | United States | $0.472B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.472B | 0.00 |
DocGo (DCGO) | United States | $0.453B | 17.08 |
InnovAge Holding (INNV) | United States | $0.449B | 0.00 |
Enhabit (EHAB) | United States | $0.406B | 35.09 |
QDM (QDMI) | Hong Kong, SAR China | $0.335B | 8.78 |
Nutex Health (NUTX) | United States | $0.314B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.253B | 0.00 |
LifeMD (LFMD) | United States | $0.248B | 0.00 |
Beauty Health (SKIN) | United States | $0.194B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.193B | 0.00 |
Sera Prognostics (SERA) | United States | $0.140B | 0.00 |
Biodesix (BDSX) | United States | $0.122B | 0.00 |
So-Young (SY) | China | $0.116B | 19.63 |
Ascend Wellness Holdings (AAWH) | United States | $0.086B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.078B | 0.00 |
ModivCare (MODV) | United States | $0.071B | 3.85 |
Oncology Institute (TOI) | United States | $0.064B | 0.00 |
NeueHealth (NEUE) | United States | $0.061B | 1.61 |
OncoCyte (OCX) | United States | $0.046B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.035B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.020B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.015B | 0.00 |
Pheton Holdings (PTHL) | China | $0.014B | 0.00 |
KindlyMD (KDLY) | United States | $0.013B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.007B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
XWELL (XWEL) | United States | $0.006B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
ISpecimen (ISPC) | United States | $0.002B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |